Age > 65 yrs
|
1
|
Structural lung disease (e.g. COPD)
|
2
|
Previous antibiotic treatment
|
2
|
Late onset (5 or more days after admission)
|
3
|
Invasive or non-invasive mechanical ventilation on onset date
|
3
|
Extrapulmonary organ failure
|
4
|
1b. PEG therapeutic recommendations for HAP/VAP depending on the complicated pathogen risk score (CPRS)
|
Group I (CPRS = 1 or 2)
|
Aminopenicillin/BLI or cephalosporin 2/3a or quinolone 3/4 or carbapenem 2
|
Group II (CPRS = 3 to 5)
|
Acylaminopenicillin/BLI or cephalosporin 3b/4 or quinolone 2/3 or carbapenem 1
|
Group III (CPRS = 6 and more)
|
Cephalosporin 3b/4 or acylaminopenicilline/BLI or carbapenem 1
|
|
Always in combination with either Quinolone 2/3 or aminoglycoside*
|